Status:
UNKNOWN
The Effect of Positional Therapy on Symptoms of Gastroesophageal Reflux Disease: A Prospective Pilot Study
Lead Sponsor:
MetroHealth Medical Center
Conditions:
Gastro Esophageal Reflux
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Gastroesophageal reflux disease related symptoms are reported by 10-20% of the adult population and of those 50-75% report symptoms during sleep time. The prevalence of nocturnal GERD (nGERD) is estim...
Detailed Description
Study Aims 1. The primary outcome of the study is to determine if positional therapy, using the LEFT device, is effective in improving nighttime GERD-related symptoms. 2. The secondary outcome of the...
Eligibility Criteria
Inclusion
- Patients over the age of 18 who have proven GERD (with nighttime heartburn at least 3 days a week).
- Agree to undergo sleep positioning therapy.
- Able to read, understand, and complete study questionnaires.
- Have mobile phones with an operating system (Android or iOS) that supports the LEFT device.
Exclusion
- 1\. Patients who are under the age of 18.
Key Trial Info
Start Date :
March 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 21 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04500288
Start Date
March 4 2021
End Date
May 21 2024
Last Update
June 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Metrohealth Medical Center
Cleveland, Ohio, United States, 44109